MYHIBBIN 200 mg/mL
MYCOPHENOLATE MOFETIL · SUSPENSION · Azurity Pharmaceuticals, Inc.
No Recall History
Plain English
MYHIBBIN is a suspension containing mycophenolate mofetil at 200 mg/mL, taken oral. Manufactured by Azurity Pharmaceuticals, Inc..
Key Facts
- Brand Name
- MYHIBBIN
- Generic Name
- MYCOPHENOLATE MOFETIL
- NDC Code (Product)
24338-018- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Strength
- 200 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA216482
- Marketing Start
- 06/10/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is MYHIBBIN used for?
MYHIBBIN contains MYCOPHENOLATE MOFETIL. It is a suspension taken oral. Consult your doctor for specific uses.
Is MYHIBBIN a controlled substance?
MYHIBBIN is not classified as a controlled substance by the DEA.
What is the generic name for MYHIBBIN?
The generic name for MYHIBBIN is MYCOPHENOLATE MOFETIL. There are 11 other brand versions of MYCOPHENOLATE MOFETIL.
What is the NDC code for MYHIBBIN 200 mg/mL?
The NDC (National Drug Code) for MYHIBBIN 200 mg/mL is 24338-018, listed by Azurity Pharmaceuticals, Inc..
Other Mycophenolate Brands
See all →- Mycophenolate Mofetil500 mg/10781-5175
- mycophenolate mofetil250 mg/10904-7466
- Mycophenolate mofetil500 mg/155154-3571
- mycophenolate mofetil250 mg/150268-557
- Mycophenolate mofetil500 mg/160687-438
- Mycophenolate mofetil250 mg/164380-726
- Mycophenolate Mofetil200 mg/mL66689-307
- Mycophenolate Mofetil200 mg/mL69238-1595
- CellCept200 mg/mL0004-0261
- Mycophenolate Mofetil500 mg/20mL54288-141
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)